348 related articles for article (PubMed ID: 6215992)
21. [Distribution of anti-rubella virus antibodies in a female population sample of the community of Perugia and serological results of an anti-rubella vaccination experiment].
Iorio AM; Rivosecchi P; Fanelli M; Pitzurra M
Boll Ist Sieroter Milan; 1972; 51(5):405-9. PubMed ID: 4656955
[No Abstract] [Full Text] [Related]
22. Studies on live rubella vaccine. VI. Seroepidemiological surveillance and immunization of adolescents in high school.
Minekawa Y; Takahashi M; Ueda S; Ogino T
Biken J; 1975 Sep; 18(3):149-54. PubMed ID: 1191245
[TBL] [Abstract][Full Text] [Related]
23. [Immune response of rubella vaccine in the populations with different age groups].
Xiong XW; Diao LD; Yan XL
Zhonghua Liu Xing Bing Xue Za Zhi; 1997 Aug; 18(4):227-9. PubMed ID: 9812525
[TBL] [Abstract][Full Text] [Related]
24. Studies on the live attenuated rubella virus vaccine. III. Clinical trials with rubella virus (Takahashi strain) vaccine in children and women.
Yamane Y; Nagashima T; Asahara T; Nagamine T; Kawakubo Y
Kitasato Arch Exp Med; 1974 Sep; 47(3):89-100. PubMed ID: 4459505
[No Abstract] [Full Text] [Related]
25. [Studies on rubella vaccination in adult females. I: Clinical and laboratory studies on clinical reactions].
Nakazono N
Hokkaido Igaku Zasshi; 1984 Mar; 59(2):180-91. PubMed ID: 6745839
[TBL] [Abstract][Full Text] [Related]
26. Prevalence of rubella antibody in school going girls.
Yadav S; Wadhwa V; Chakarvarti A
Indian Pediatr; 2001 Mar; 38(3):280-3. PubMed ID: 11255307
[No Abstract] [Full Text] [Related]
27. [Rubella vaccination using Cendehill's live virus vaccine].
Vivell O; Merschmann E; Lips G; Reiss G
Arch Kinderheilkd; 1969 Sep; 179(3):259-66. PubMed ID: 5350790
[No Abstract] [Full Text] [Related]
28. Susceptibility to rubella and borderline immunity.
Fogel A; Barnea B; Gerichter CB
Isr J Med Sci; 1983 Oct; 19(10):934-5. PubMed ID: 6363349
[TBL] [Abstract][Full Text] [Related]
29. Vaccination with a live RA 27/3 strain rubella vaccine (Rudivax), a follow-up study.
Suni JI; Meurman O; Hirvonen P; Vaheri A
Vaccine; 1984 Dec; 2(4):281-3. PubMed ID: 6531969
[TBL] [Abstract][Full Text] [Related]
30. Prospective evaluation of pregnant women vaccinated against rubella in southern Brazil.
Minussi L; Mohrdieck R; Bercini M; Ranieri T; Sanseverino MT; Momino W; Callegari-Jacques SM; Schuler-Faccini L
Reprod Toxicol; 2008 Jan; 25(1):120-3. PubMed ID: 17977696
[TBL] [Abstract][Full Text] [Related]
31. [Importance of active and passive anti-rubella immunoprophylaxis].
Del Piano M
Nuovi Ann Ig Microbiol; 1979; 30(6):404-20. PubMed ID: 554136
[No Abstract] [Full Text] [Related]
32. Development of a rubella vaccination strategy: contribution of a rubella susceptibility study of women of childbearing age in Kyrgyzstan, 2001.
Malakmadze N; Zimmerman LA; Uzicanin A; Shteinke L; Caceres VM; Kasymbekova K; Sozina I; Glasser JW; Joldubaeva M; Aidyralieva C; Icenogle JP; Strebel PM; Reef SE
Clin Infect Dis; 2004 Jun; 38(12):1780-3. PubMed ID: 15227627
[TBL] [Abstract][Full Text] [Related]
33. Rubella--a reappraisal.
Wynchank S; Barron J; Kipps A
S Afr Med J; 1977 Dec; 52(24):953-6. PubMed ID: 609965
[TBL] [Abstract][Full Text] [Related]
34. [On vaccination against rubella with live attenuated virus (strain RA 27-3)].
Monaci V; Giovannelli G; Nardi G; Siegert V; Tanzi ML; Bellelli E; Chiusi O
Ann Sclavo; 1974; 16(3):231-42. PubMed ID: 4473961
[No Abstract] [Full Text] [Related]
35. HLA and the rubella-specific immune response following vaccination.
Van Eden W; UytdeHaag F; Loggen HG; Plantinga AD; De Vries RR; Van Rood JJ
Exp Clin Immunogenet; 1984; 1(2):70-4. PubMed ID: 6400993
[TBL] [Abstract][Full Text] [Related]
36. [Screening for rubella antibodies in newly employed women at the National Hospital].
Lingaas E; Degré M
Tidsskr Nor Laegeforen; 1982 Sep; 102(25):1272-3. PubMed ID: 7164071
[No Abstract] [Full Text] [Related]
37. [Prevention of connatal rubella].
Sandow D
Kinderarztl Prax; 1978 Dec; 46(12):636-43. PubMed ID: 366237
[No Abstract] [Full Text] [Related]
38. [Evaluation of the immunological status of a sample of the female population 3 years after vaccination against rubella].
Becchi A; Fornero M
Nuovi Ann Ig Microbiol; 1981; 32(4):247-52. PubMed ID: 7346775
[No Abstract] [Full Text] [Related]
39. Cost-benefit analysis of rubella screening.
Preblud SR; Brandling-Bennett AD; Hinman AR
N Engl J Med; 1979 Jul; 301(4):217-8. PubMed ID: 109761
[No Abstract] [Full Text] [Related]
40. Vaccination of schoolgirls against rubella. Assessment of serological status and a comparative trial of Wistar RA 27/3 and Cendehill strain live attenuated rubella vaccines in 13-year-old schoolgirls in Dudley.
Freestone DS; Reynolds GM; McKinnon JA; Prydie J
Br J Prev Soc Med; 1975 Dec; 29(4):258-61. PubMed ID: 766879
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
